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Comparison of central corneal thickness measurement with Sirius Topographer and Nidek Axial Length Scan
Sir, I read with interest the article by Duman et al. [1] on "Comparison of anterior segment measurements using Sirius Topographer ® and Nidek Axial Length-Scan ® (AL-scan) with assessing repeatability in patients with cataract" (mean age, 71.79 ± 7.91 years). We would like to mention a few points in relation to central corneal thickness (CCT) measurement in their study.
The study reports mean CCT of 523.46 ± 40.58 µm with AL-scan and 545.32 ± 41.38 µm with Sirius Topographer in 43 eyes, for the first measurement. Using the same devices, we found lower mean CCT with AL-scan and Sirius Topographer, which was 507.43 ± 33.54 and 512.08 ± 33.1 µm, respectively, in 127 healthy eyes (mean age, 35.91 + 7.7 years). [2] The present study [1] found a mean difference of 19.759 for CCT measurement and poor agreement with 95% limits of agreement (LoA) to be 17.220-22.299 (P = 0.00) between the 2 devices. Our study reported a mean difference of − 4.6 µm for CCT and high level of agreement (95% LoA: -12.2 to 2.9, P = 0.26) between the 2 devices.
One of the reasons for the significant mean difference in CCT between the 2 devices in the present study could be because of the fact that the measurements were taken between 10 am and 5 pm which could have affected the diurnal variation in CCT, when compared with our study where the CCT measurements were obtained between 3 pm and 5 pm. Furthermore, the difference in mean CCT between the 2 studies could be because of the difference in age, sample size, and ethnicity [3] of the population studied.
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Sir, The health belief model (HBM) is a classical behavior theory that explains health behaviors. It contains cognitive constructs (including perceived susceptibility, benefits, barrier; cues to action, and self-efficacy) that predict why people take actions to control their illnesses. [1] [2] [3] [4] Applicability of HBM in glaucoma medication adherence has not been explored fully among the Indian population. An attempt was made to discover this using a semi-structured, pretested, interview schedule based on HBM.
The following HBM-related factors [ Fig. 1 ] were associated with low adherence: poor understanding of the disease and importance of medications, lack of self-efficacy (individual belief regarding their capabilities to carry out a specific task to achieve a desired outcome), [5] side effects of glaucoma medications, additional medications for other comorbidities, lack of family and social support, and no follow-up visit in the past 6 months.
By understanding the cognitive constructs of poor adherence behavior, we can circumvent them by formulating a targeted approach. The physician can play a key role by educating the patient about the nature of the disease, its prognosis with emphasis on the impact of medication and their expected side effects. Patients have to be trained to self-administer the drops. The family of the patient needs to be involved in the treatment plan.
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